Effects of atorvastatin on the HDL subpopulation profile of coronary heart disease patients

Journal of Lipid Research - Tập 43 Số 10 - Trang 1701-1707 - 2002
Bela F. Asztalos1, Katalin V. Horvath1, Judith McNamara1, Paul S. Roheim2, Joel J. Rubinstein3, Ernst J. Schaefer1
1Lipid Metabolism Laboratory, Jean Mayer USDA Human Nutrition Center on Aging at Tufts University and Division of Endocrinology, Metabolism, Diabetes, and Molecular Medicine, New England Medical Center, Boston, MA
2Physiology Department, Louisiana State University Medical Center, New Orleans, LA
3Cardiology Division, Newton-Wellesley Hospital, Newton, MA

Tóm tắt

Từ khóa


Tài liệu tham khảo

Gordon, 1977, High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study, Am. J. Med., 62, 707, 10.1016/0002-9343(77)90874-9

Jacobs, 1985, High-density lipoprotein cholesterol and coronary heart disease cardiovascular disease and all-cause mortality (abstr.), Circulation, 72, 111

Miller, 1977, The Tromso Heart Study. High-density lipoprotein and coronary heart disease: a prospective case-control study, Lancet, 1, 965, 10.1016/S0140-6736(77)92274-7

Enger, 1979, High-density lipoprotein cholesterol and myocardial infarction or sudden coronary death: a prospective case-control study in middle-aged men of the Oslo study, Artery., 5, 170

Wilson, 1998, Prediction of coronary heart disease using risk factor categories, Circulation., 97, 1837, 10.1161/01.CIR.97.18.1837

Goldburt, 1997, Isolated low HDL cholesterol as a risk factor for coronary heart disease mortality: a 21-year follow-up of 8000 men, Arterioscler. Thromb. Vasc. Biol., 17, 107, 10.1161/01.ATV.17.1.107

Cheung, 1991, Altered particle size distribution of apolipoprotein A-I containing lipoproteins in subjects with coronary heart disease, J. Lipid Res., 32, 383, 10.1016/S0022-2275(20)42061-9

von Eckardstein, 1994, Physiological role and clinical relevance of high density lipoprotein subclasses, Curr. Opin. Lipidol., 5, 404, 10.1097/00041433-199412000-00003

Puchois, 1987, Apoliprotein A-I containing lipoproteins in coronary artery disease, Atherosclerosis., 68, 35, 10.1016/0021-9150(87)90091-8

Campos, 1995, Predominance of large LDL and reduced HDL-2 cholesterol in normolipidemic men with coronary artery disease, Arterioscler. Thromb. Vasc. Biol., 15, 1043, 10.1161/01.ATV.15.8.1043

Sweetnam, 1994, Associations of HDL2 and HDL3 cholesterol subfractions with the development of ischemic heart disease in British men, Circulation., 90, 769, 10.1161/01.CIR.90.2.769

Asztalos, 2000, Distribution of ApoA-I-containing HDL subpopulations in patients with Coronary Heart Disease, Arterioscler. Thromb. Vasc. Biol., 20, 2670, 10.1161/01.ATV.20.12.2670

Fruchart, 1992, Apolipoprotein A-containing lipoprotein particles: Physiological role, Quantification, and clinical significance, Clin. Chem., 38, 793, 10.1093/clinchem/38.6.793

Mowri, 1992, Different reactivities of high-density lipoprotein2 subfractions with hepatic lipase, J. Lipid Res., 33, 1269, 10.1016/S0022-2275(20)40541-3

Castro, 1988, Early incorporation of cell-derived cholesterol into pre-β-migrating high-density lipoprotein, Biochemistry., 27, 25, 10.1021/bi00401a005

Miida, 1992, Regulation of the concentration of preβ high-density lipoprotein in normal plasma by cell membranes and lecithin-cholesterol acyltransferase activity, Biochemistry., 31, 11112, 10.1021/bi00160a022

Asztalos, 1993, Two-dimensional electrophoresis of plasma lipoproteins: recognition of new apo A-I-containing subpopulations, Biochim. Biophys. Acta., 1169, 291, 10.1016/0005-2760(93)90253-6

Asztalos, 1997, Normolipidemic subjects with low HDL cholesterol levels have altered HDL subpopulations, Arterioscler. Thromb. Vasc. Biol., 17, 1885, 10.1161/01.ATV.17.10.1885

Thompson, 1997, What targets should lipid-modulating therapy achieve to optimize the prevention of coronary heart disease?, Atherosclerosis., 131, 1, 10.1016/S0021-9150(97)06084-X

Gould, 1998, Cholesterol reduction yields clinical benefit: impact of statin trials, Circulation., 97, 946, 10.1161/01.CIR.97.10.946

Pedersen, 2001, Pro and Con: Low-density lipoprotein cholesterol lowering is and will be the key to the future of lipid management, Am. J. Cardiol., 87, 8B, 10.1016/S0002-9149(01)01449-7

Olsson, 2001, Statin therapy and reduction in low-density lipoprotein cholesterol: initial clinical data on the potent new statin rosuvastatin, Am. J. Cardiol., 87, 33B, 10.1016/S0002-9149(01)01455-2

1993, Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel II), J. Am. Med. Assoc., 269, 3015, 10.1001/jama.1993.03500230097036

1998, Prevention of coronary heart disease in clinical practice: recommendations of the Second Joint Task Force of European and Other Societies on Coronary Prevention, Eur. Heart J., 9, 1434

Person, 2000, The imperative to raise low levels of high density lipoprotein cholesterol - a better clinical strategy in the prevention and treatment of coronary artery disease, Am. J. Cardiol., 86, 1L

Asztalos, 2002, Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients, Atherosclerosis., 164, 361, 10.1016/S0021-9150(02)00149-1

McNamara, 1987, Automated enzymatic standardized lipid analyses for plasma and lipoprotein fractions, Clin. Chim. Acta., 166, 1, 10.1016/0009-8981(87)90188-4

Warnick, 1982, Dextran sulfate-Mg procedure for quantitation of high density lipoprotein cholesterol, Clin. Chem., 28, 1379, 10.1093/clinchem/28.6.1379

Nguyen, 1989, Improved methods for separation of total HDL and subclasses, Clin. Chem., 35, 1086

McNamara, 1995, Immunoseparation method for measuring low-density lipoprotein cholesterol directly from serum evaluated, Clin. Chem., 41, 232, 10.1093/clinchem/41.2.232

Contois, 1996, Reference intervals for plasma apolipoprotein A-I determined with a standardized commercial immunoturbidometric assay: results from the Framingham Offspring Study, Clin. Chem., 42, 515, 10.1093/clinchem/42.4.515

Johnson, 1990, Autoradiography using storage phosphor technology, Electrophoresis., 11, 355, 10.1002/elps.1150110503

2001, Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults, J. Am. Med. Assoc., 285, 2486, 10.1001/jama.285.19.2486

1988, Report of the National Cholesterol Education Program Expert Panel on Detection, Evaluation, and Treatment of High Cholesterol in Adults, Arch. Intern. Med., 148, 36, 10.1001/archinte.1988.00380010040006

Gordon, 1989, High density lipoprotein cholesterol and cardiovascular disease. Four prospective American studies, Circulation., 79, 8, 10.1161/01.CIR.79.1.8

Asztalos, 2001, Subpopulations of high density lipoproteins in homozygous and heterozygous Tangier disease, Arterioscler. Thromb. Vasc. Biol., 156, 217

Guerin, 2000, Action of Atorvastatin in Combined Hyperlipidemia: Preferencial Reduction of Cholesterol Ester Transfer from HDL to VLDL1 Particles, Arterioscler. Thromb. Vasc. Biol., 20, 189, 10.1161/01.ATV.20.1.189